“The sensitivity of current factors used to predict malignant intraductal papillary mucinous neoplasm (IPMN) is not high,” says Masao Tanaka (Kyushu University, Japan). “Thus, more sensitive factors ...
Early detection and interception of pancreatic ductal adenocarcinoma (PDAC) remain the only realistic strategies to reduce ...
Influence of underlying liver disease on response to sorafenib in patients with advanced hepatocellular carcinoma (HCC). Methods: An epidemiologic questionnaire was administered to patients (pts) with ...
IPMN tumors are being recognized with increasing frequency and appear to have a better prognosis than adenocarcinoma of the pancreas. This report highlights the increased risk for other benign or ...
First-in-human study of MM-141: A novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3. Overall survival in intermediate-stage hepatocellular carcinoma (HCC) patients after first ...
Researchers report two breakthroughs in understanding pancreatic cancer: the development of the first mouse model that simulates a precursor lesion called intraductal papillary mucinous neoplasia ...
The majority of pancreatic cancers are thought to evolve through a series of hyperplastic and dysplastic ductal lesions termed PanIN. Normal ductal epithelium progresses to invasive adenocarcinomas ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — If a branch duct-intraductal papillary mucinous neoplasm grows at a rate of 5 mm or more annually, ...
Dear Dr. Roach: Are you aware of the possibility of pancreatitis resulting from long-term vitamin D2 supplementation? I was diagnosed with IPMN with chronic pancreatitis after being on 50,000 IU of ...
Sonography in a 75-year-old man with cingulate upper abdominal pain showed an greatly enlarged pancreas with multiple cystic elements. Magnetic resonance cholangiopancreatography (MRCP) identified a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results